News | Peripheral Artery Disease (PAD) | October 12, 2016

Society for Vascular Surgery Announces New PAD Reporting Standards

Update of 1997 peripheral artery disease treatment standards reflects boom in endovascular devices and techniques

Society for Vascular Surgery, SVS, new PAD reporting standards, peripheral artery disease

October 12, 2016 — The Society for Vascular Surgery (SVS) has released new reporting standards focused on endovascular treatment of chronic lower extremity peripheral artery disease (PAD). Recommended reporting standards for lower extremity ischemia were last published by the SVS in 1997.

The last decade has seen a tremendous increase in the variety of endovascular devices and techniques to treat occlusive disease, the report authors state, and “the literature surrounding therapy for endovascular arterial disease consists of mixed-quality manuscripts without clear standardization.”

This document clarifies and updates the 1997 standards, specifically for reports on endovascular treatment. The document is divided into sections:

  • Claudication Reporting;
  • Critical Limb Ischemia Reporting;
  • Pre-intervention Assessment and Non-anatomic Treatment;
  • Intervention;
  • Outcome Measures – Procedural; and
  • Outcome Measures – Disease Specific and Complications.

The document provides a summary for reporting endovascular revascularization techniques in the setting of chronic disease, with much of it based on prior publications and SVS-proposed standards.

It also should:

  • Serve as a guide for the design of clinical trials; and
  • Be a reference for journal editors and reviewers when considering scientific work pertaining to endovascular therapy for chronic lower extremity arterial disease.

The abstract of the standards can be read here.

For more information: www.jvascsurg.org


Related Content

News | Peripheral Artery Disease (PAD)

Nov. 4, 2024 — Royal Philips recently announced enrollment of the first patient in the U.S. THOR IDE clinical trial ...

Home November 08, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 16, 2024 – Shockwave Medical, Inc., part of Johnson & Johnson MedTech, has announced the full U.S. launch of the ...

Home September 16, 2024
Home
News | Peripheral Artery Disease (PAD)

Sept. 1, 2024 — September is Peripheral Artery Disease (PAD) Awareness Month, a time to educate and empower people to ...

Home September 04, 2024
Home
News | Peripheral Artery Disease (PAD)

May 16, 2024 — Timely diagnosis and proper management of peripheral artery disease (PAD), including coordinated care ...

Home May 16, 2024
Home
News | Peripheral Artery Disease (PAD)

May 8, 2024 — In a groundbreaking development, a study published in the Journal of Vascular Surgery reveals for the ...

Home May 08, 2024
Home
News | Peripheral Artery Disease (PAD)

March 20, 2024 — Biotronik has been granted Breakthrough Device Designation (BDD) from the US Food and Drug ...

Home March 20, 2024
Home
News | Peripheral Artery Disease (PAD)

February 12, 2024 — Sensome, a company pioneering the connected medical device revolution with the world’s smallest ...

Home February 12, 2024
Home
News | Peripheral Artery Disease (PAD)

November 10, 2023 —Getinge announced commercial availability of the iCast covered stent system in the United States for ...

Home November 10, 2023
Home
News | Peripheral Artery Disease (PAD)

October 24, 2023 — Four years ago, following a publication based on the limited data available, the U.S. Food and Drug ...

Home October 24, 2023
Home
News | Peripheral Artery Disease (PAD)

September 14, 2023 — LimFlow SA, a pioneer in the development of minimally-invasive technology for the treatment of ...

Home September 14, 2023
Home
Subscribe Now